Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Int Microbiol ; 23(2): 263-276, 2020 May.
Artigo em Inglês | MEDLINE | ID: mdl-31624974

RESUMO

Considering the emergence of multidrug resistance (MDR) in prevalent human pathogen, Mycobacterium tuberculosis (MTB), there is parallel spurt in development of novel strategies aimed to disrupt MDR. The cell envelope of MTB comprises a wealth of lipid moieties contributing towards long-term survival of pathogen that could be exploited as efficient antitubercular target owing to advancements made in mass spectrometry-based lipidomics technology. This study aimed to utilize the lipidomics approach to unveil several lipid associated changes in response to natural antimycobacterial compound vanillin (Van) in Mycobacterium smegmatis, a surrogate for MTB. Lipidomic analyses revealed that that Van alters the composition of fatty acid (FA), glycerolipid (GL), glycerophospholipid (GP), and saccharolipids (SL). Furthermore, Van leads to potentiation of ampicillin and displayed additive effect. The differential expressions of various lipid biosynthetic pathway genes by RT-PCR corroborated with the lipidomics data. Lastly, we demonstrated enhanced survival of Mycobacterium-infected Caenorhabditis elegans model in presence of Van. Thus, lipidomics approach provided detailed insight into mechanisms of membrane disruption by Van in Mycobacterium smegmatis. Our work offers the basis of further understanding the regulation of lipid homeostasis in MTB so that better therapeutic targets could be identified to combat MDR.


Assuntos
Benzaldeídos/farmacologia , Membrana Celular/efeitos dos fármacos , Metabolismo dos Lipídeos/efeitos dos fármacos , Mycobacterium smegmatis/efeitos dos fármacos , Antituberculosos/farmacologia , Proteínas de Bactérias/efeitos dos fármacos , Parede Celular/química , Parede Celular/efeitos dos fármacos , Ácidos Graxos/metabolismo , Glicerofosfolipídeos/metabolismo , Glicolipídeos/metabolismo , Humanos , Lipidômica/métodos , Mycobacterium tuberculosis/efeitos dos fármacos
2.
iScience ; 24(2): 102054, 2021 Feb 19.
Artigo em Inglês | MEDLINE | ID: mdl-33521604

RESUMO

The availability of a safe and effective vaccine would be the eventual measure to deal with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) threat. Here, we have assessed the immunogenicity and protective efficacy of inactivated SARS-CoV-2 vaccine candidates BBV152A, BBV152B, and BBV152C in Syrian hamsters. Three dose vaccination regimes with vaccine candidates induced significant titers of SARS-CoV-2-specific IgG and neutralizing antibodies. BBV152A and BBV152B vaccine candidates remarkably generated a quick and robust immune response. Post-SARS-CoV-2 infection, vaccinated hamsters did not show any histopathological changes in the lungs. The protection of the hamster was evident by the rapid clearance of the virus from lower respiratory tract, reduced virus load in upper respiratory tract, absence of lung pathology, and robust humoral immune response. These findings confirm the immunogenic potential of the vaccine candidates and further protection of hamsters challenged with SARS-CoV-2. Of the three candidates, BBV152A showed the better response.

3.
Nat Commun ; 12(1): 1386, 2021 03 02.
Artigo em Inglês | MEDLINE | ID: mdl-33654090

RESUMO

The COVID-19 pandemic is a global health crisis that poses a great challenge to the public health system of affected countries. Safe and effective vaccines are needed to overcome this crisis. Here, we develop and assess the protective efficacy and immunogenicity of an inactivated SARS-CoV-2 vaccine in rhesus macaques. Twenty macaques were divided into four groups of five animals each. One group was administered a placebo, while three groups were immunized with three different vaccine candidates of BBV152 at 0 and 14 days. All the macaques were challenged with SARS-CoV-2 fourteen days after the second dose. The protective response was observed with increasing SARS-CoV-2 specific IgG and neutralizing antibody titers from 3rd-week post-immunization. Viral clearance was observed from bronchoalveolar lavage fluid, nasal swab, throat swab and lung tissues at 7 days post-infection in the vaccinated groups. No evidence of pneumonia was observed by histopathological examination in vaccinated groups, unlike the placebo group which exhibited interstitial pneumonia and localization of viral antigen in the alveolar epithelium and macrophages by immunohistochemistry. This vaccine candidate BBV152 has completed Phase I/II (NCT04471519) clinical trials in India and is presently in phase III, data of this study substantiates the immunogenicity and protective efficacy of the vaccine candidates.


Assuntos
Vacinas contra COVID-19/uso terapêutico , SARS-CoV-2/patogenicidade , Animais , Anticorpos Neutralizantes/imunologia , Anticorpos Antivirais/imunologia , Ensaio de Imunoadsorção Enzimática , Feminino , Imuno-Histoquímica , Linfócitos/imunologia , Linfócitos/metabolismo , Macaca mulatta , Masculino , Pneumonia/imunologia , Pneumonia/metabolismo
4.
Infect Disord Drug Targets ; 20(4): 467-485, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-31241021

RESUMO

BACKGROUND: Tuberculosis (TB) remains a global infectious disorder for which efficient therapeutics are elusive. Nature is a source of novel pharmacologically active compounds with many potential drugs being derived directly or indirectly from plants, microorganisms and marine organisms. OBJECTIVE: The present study aimed to elucidate the antimycobacterial potential of Geraniol (Ger), monoterpene alcohol, against Mycobacterium smegmatis. METHODS: Disrupted membrane integrity was studied by membrane permeability assay and PI uptake. Cell surface phenotypes were studied by colony morphology, sliding motility and cell sedimentation rate. Lipidome profile was demonstrated by thin-layer chromatography and liquid chromatography-electrospray ionization mass spectrometry. Amendment in iron homeostasis was assessed by using iron chelator ferrozine and ferroxidase assay while genotoxicity was estimated with EtBr and DAPI staining. Biofilm formation was measured by staining, dry mass and metabolic activity using crystal violet. Cell adherence was examined microscopically and spectrophotometrically. RESULTS: We found the antimycobacterial activity of Ger to be 500 µg/ml against M. smegmatis. Underlying mechanisms revealed impaired cell surface phenotypes. Lipidomics analysis exposed profound decrement of mycolic acids, phosphatidylinositol mannosides and triacylglycerides which are crucial for MTB pathogenicity. We further explored that Ger impairs iron homeostasis and leads to genotoxic stress. Moreover, Ger inhibited the potential virulence attributes such as biofilm formation and cell adherence to both polystyrene surface and epithelial cells. Finally, we have validated all the disrupted phenotypes by RT-PCR which showed good correlation with the biochemical assays. CONCLUSION: Taken together, the current study demonstrates the antimycobacterial mechanisms of Ger, which may be exploited as an effective candidate of pharmacological interest.


Assuntos
Monoterpenos Acíclicos/farmacologia , Antituberculosos/farmacologia , Membrana Celular/efeitos dos fármacos , Monoterpenos/farmacologia , Mycobacterium smegmatis/patogenicidade , Biofilmes/efeitos dos fármacos , Biofilmes/crescimento & desenvolvimento , Adesão Celular/efeitos dos fármacos , Membrana Celular/fisiologia , Humanos , Lipidômica , Microscopia Eletrônica de Transmissão , Mycobacterium smegmatis/efeitos dos fármacos , Virulência/efeitos dos fármacos
5.
J Glob Antimicrob Resist ; 10: 228-237, 2017 09.
Artigo em Inglês | MEDLINE | ID: mdl-28735047

RESUMO

OBJECTIVES: Novel strategies to overcome multidrug resistance (MDR) in Tuberculosis (TB) still remain a concern. Usage of natural compounds nowadays to surmount the increasing burden of MDR-TB has shown promising results. The aim of this study was to evaluate the antimycobacterial potential of sesamol (Ses) a natural phenolic compound against Mycobacterium smegmatis, a surrogate for MTB and its underlying mechanism of action along with its effect on mycobacterial virulence traits. METHODS: Cell surface phenotypes were estimated microscopically and spectrophotometrically respectively. Membrane parameters were assessed using propidium iodide (PI) uptake, passive diffusion of drug with substrate EtBr and phenotypic susceptibility assay. Changes in lipid profiles were estimated by lipase assay. Oxidative and genotoxic damage were studied using fluorescent probes DCFDA and DAPI. Biofilm formation was studied using crystal violet and calcoflour white staining probes along with biomass measurement. Cell adherence was estimated using buccal epithelial cells. RESULTS: We observed that antimycobacterial activity of Ses was 6mM and it enhances the efficiency of known anti-TB drugs. Ses affects cell surface phenotypes as displayed by altered colony morphology, impaired sliding motility and enhanced cell sedimentation rate. Membrane perturbation was revealed by hypersensitivity against SDS, reduced PI uptake, enhanced passive diffusion and lipase activity. In addition, Ses leads to oxidative and DNA damage along with abrogated iron homeostasis. Furthermore, we uncover phenotypes related to virulence like inhibited biofilm formation and cell adherence to buccal epithelial cells. CONCLUSION: This study for the first time establishes the anti-mycobacterial potential of Ses that may be further exploited for improving the therapeutic strategies and warrants further attention.


Assuntos
Benzodioxóis/farmacologia , Células Epiteliais/citologia , Mycobacterium smegmatis/patogenicidade , Fenóis/farmacologia , Animais , Aderência Bacteriana/efeitos dos fármacos , Células Cultivadas , Farmacorresistência Bacteriana Múltipla , Células Epiteliais/efeitos dos fármacos , Células Epiteliais/microbiologia , Camundongos , Testes de Sensibilidade Microbiana , Mycobacterium smegmatis/efeitos dos fármacos , Fenótipo , Virulência/efeitos dos fármacos
6.
Recent Pat Biotechnol ; 10(2): 167-174, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27652611

RESUMO

BACKGROUND: Tuberculosis caused by Mycobacterium tuberculosis (MTB) is currently a major health concern due to its growing mortality rates around the world. The known anti-TB drugs although are available for the treatment but it produces adverse side effects on the human health and are also not very cost effective. Moreover, emergence of multidrug resistance (MDR) phenomenon has also compromised their activities. OBJECTIVE: Hence there is an urgent need to search novel drugs and compounds from natural sources having lesser side effects which have proved to be vital and widely used nowadays. Many recent studies have been established which show promising antimycobacterial activities against MTB. RESULT: This review summarizes the various naturally occurring active compounds acting on different targets against MTB. Moreover, it also deals with the compounds having patent perspective. CONCLUSION: Together, the article laid emphasis on reverting towards the natural compounds so that further work is carried out to exploit their therapeutic interventions.


Assuntos
Antituberculosos/farmacologia , Produtos Biológicos/farmacologia , Resistência a Múltiplos Medicamentos/efeitos dos fármacos , Mycobacterium tuberculosis/efeitos dos fármacos , Tuberculose Pulmonar/tratamento farmacológico , Humanos , Patentes como Assunto
7.
BMJ Case Rep ; 20162016 Jan 28.
Artigo em Inglês | MEDLINE | ID: mdl-26823363

RESUMO

A 29-year-old previously healthy woman, a doctor, was diagnosed with remitting relapsing multiple sclerosis after fulfilling McDonald's criteria for the diagnosis of definite multiple sclerosis. Despite 22 months of immunomodulatory treatment, the feasibility of continuing to train in a stressful specialty of medicine became an ethical and practical dilemma. Fitness for practice and career advancement among doctors with illnesses or having cognitive and physical decline from disease and/or ageing is a global problem. The need for addressing this issue in a compassionate and comprehensive manner is discussed. Cognitive and physical fitness are required in doctors and other healthcare workers since medical errors/adverse events are commonplace in medical practice. The public welfare is equally important in this global problem.


Assuntos
Anestesiologia , Internato e Residência , Esclerose Múltipla Recidivante-Remitente , Inabilitação do Médico , Adulto , Anestesiologia/educação , Anestesiologia/normas , Avaliação da Deficiência , Feminino , Humanos , Trinidad e Tobago
8.
Braz J Infect Dis ; 20(6): 585-591, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27755980

RESUMO

Novel strategies to combat the ever increasing burden of drug resistance in Mycobacterium tuberculosis (MTB) causing tuberculosis (TB) remains a global concern. The ability of MTB to sense and adapt to restricted iron conditions in the hostile environment is essential for their survival and confers the basis of their success as dreadful pathogen. The striking and clinically relevant virulence trait of MTB is its ability to form biofilms and adhere to the host cells. The present study elucidated the effect of iron deprivation on biofilm formation and cell adherence of Mycobacterium smegmatis, a non-pathogenic surrogate of MTB. Firstly, we showed that iron deprivation leads to enhanced cell sedimentation rate and altered colony morphology depicting alterations in cell surface envelope properties. We explored that biofilm formation and cell adherence to polystyrene surface as well as human oral epithelial cells were considerably reduced under iron deprivation both in presence of 2,2 BP (iron chelator) and siderophore mutant Δ011-14 strain. We further investigated that the potency of three first line anti-TB drugs (Isoniazid, Ethambutol, Rifampicin) to inhibit both biofilm formation and cell adhesion were enhanced under iron deprivation in contrast to the drugs when tested alone. Taken together, by virtue of the indispensability of iron for functional virulence traits in mycobacteria, iron deprivation strategies could be further exploited against this notorious human pathogen to explore novel drug targets.


Assuntos
Aderência Bacteriana/efeitos dos fármacos , Biofilmes/crescimento & desenvolvimento , Células Epiteliais/microbiologia , Ferro/farmacologia , Mycobacterium smegmatis/patogenicidade , Virulência , Biofilmes/efeitos dos fármacos , Humanos
9.
Int J Mycobacteriol ; 5(4): 460-468, 2016 12.
Artigo em Inglês | MEDLINE | ID: mdl-27931688

RESUMO

OBJECTIVE/BACKGROUND: Tuberculosis (TB) remains a global threat, claiming one-third of the population annually. The ever increasing emergence of multidrug-resistant TB (MDR-TB) is the major impediment to effective anti-TB therapy. Under such circumstances, deciphering the antimycobacterial potential of natural compounds has gained considerable prominence. This study evaluated the antimycobacterial activity of vanillin (Van), a natural food-flavoring agent and preservative, along with its potential mechanisms of action. METHODS: Drug susceptibilities were performed using broth microdilution, spot, and filter-disc assays. Membrane damage was studied by nitrocefin hydrolysis and electron microscopy. Virulence attributes were assessed by biofilm formation and cell adherence. Iron availability was estimated by enzymatic (ferroxidase) assay. RESULTS: We found that the antimycobacterial activity of Van against Mycobacterium smegmatis (a surrogate of Mycobacterium tuberculosis) is 125µg/mL. Additionally, we observed disruption of membrane homeostasis in the presence of Van, as revealed by enhanced membrane permeability and transmission electron microscopy images showing a disturbed cell envelope. Concomitant with our findings, we also observed that Van leads to enhanced drug susceptibility to membrane targeting known anti-TB drugs. Furthermore, Van affects significant virulence traits of Mycobacterium by inhibiting biofilm formation and cell adhesion. Finally, we observed that Van disrupted iron homeostasis as displayed by hypersensitivity to iron deprivation. CONCLUSION: The results established for the first time that Van could be an effective antimycobacterial agent that could be exploited further in treating mycobacterial infections.


Assuntos
Antituberculosos/farmacologia , Benzaldeídos/farmacologia , Membrana Celular/efeitos dos fármacos , Homeostase/efeitos dos fármacos , Ferro/metabolismo , Mycobacterium smegmatis/fisiologia , Mycobacterium smegmatis/patogenicidade , Bacteriólise , Biofilmes/efeitos dos fármacos , Biofilmes/crescimento & desenvolvimento , Adesão Celular/efeitos dos fármacos , Membrana Celular/fisiologia , Humanos , Testes de Sensibilidade Microbiana , Microscopia Eletrônica de Transmissão , Virulência/efeitos dos fármacos
10.
Braz. j. infect. dis ; 20(6): 585-591, Nov.-Dec. 2016. graf
Artigo em Inglês | LILACS | ID: biblio-828168

RESUMO

ABSTRACT Novel strategies to combat the ever increasing burden of drug resistance in Mycobacterium tuberculosis (MTB) causing tuberculosis (TB) remains a global concern. The ability of MTB to sense and adapt to restricted iron conditions in the hostile environment is essential for their survival and confers the basis of their success as dreadful pathogen. The striking and clinically relevant virulence trait of MTB is its ability to form biofilms and adhere to the host cells. The present study elucidated the effect of iron deprivation on biofilm formation and cell adherence of Mycobacterium smegmatis, a non-pathogenic surrogate of MTB. Firstly, we showed that iron deprivation leads to enhanced cell sedimentation rate and altered colony morphology depicting alterations in cell surface envelope properties. We explored that biofilm formation and cell adherence to polystyrene surface as well as human oral epithelial cells were considerably reduced under iron deprivation both in presence of 2,2 BP (iron chelator) and siderophore mutant Δ011-14 strain. We further investigated that the potency of three first line anti-TB drugs (Isoniazid, Ethambutol, Rifampicin) to inhibit both biofilm formation and cell adhesion were enhanced under iron deprivation in contrast to the drugs when tested alone. Taken together, by virtue of the indispensability of iron for functional virulence traits in mycobacteria, iron deprivation strategies could be further exploited against this notorious human pathogen to explore novel drug targets.


Assuntos
Humanos , Virulência , Aderência Bacteriana/efeitos dos fármacos , Biofilmes/crescimento & desenvolvimento , Mycobacterium smegmatis/patogenicidade , Células Epiteliais/microbiologia , Ferro/farmacologia , Biofilmes/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA